Profitability Ratios
| Ratio |
Value |
| GP Margin |
63.5% |
| EBIT Margin |
4.8% |
| EBITDA Margin |
14.2% |
| Operating Margin |
7.4% |
| Pretax Margin |
4.8% |
| Cont. Ops Margin |
2.7% |
| Net Margin |
2.7% |
| Bottom Line Margin |
2.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.72 |
| Quick Ratio |
1.29 |
| Solvency Ratio |
0.124 |
| Cash Ratio |
0.44 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.17 |
| Forward PEG |
-0.17 |
| Price/Book |
2.62 |
| Price/Sales |
1.96 |
| Price/FCF |
12.32 |
| Price/Op Cash Flow |
11.38 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3947 |
| Debt/Equity |
0.9065 |
| Debt/Capital |
0.4755 |
| Long-Term Debt/Capital |
0.4392 |
| Financial Leverage |
2.30 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-29.47 |
| Operating Cash Flow Ratio |
0.692 |
| Operating Cash Flow/Sales |
17.2% |
| Free Cash Flow/Operating Cash Flow |
92.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.84 |
| Interest Coverage |
1.7313 |
| Short-Term Operating Cash Flow Coverage |
7.61 |
| Operating Cash Flow Coverage |
0.25 |
| Capital Expenditure Coverage |
13.18 |
| Dividend + Capital Expenditure Coverage |
6.32 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
52.4881% |
| Dividend Yield |
0.7226% |
| Dividend Yield % |
0.7226% |
| Dividend Per Share |
0.6389 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
45.18 |
| EPS |
1.217 |
| Debt/Share |
32.5577 |
| Cash/Share |
4.88 |
| Book Value/Share |
33.78 |
| Tangible BV/Share |
-15.23 |
| Equity/Share |
33.78 |
| Operating Cash Flow/Share |
7.768 |
| Capital Expenditure/Share |
0.589 |
| FCF/Share |
7.178 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.559 |
| Earnings Before Tax/EBIT |
0.649 |
| Price/Fair Value |
2.62 |
| Debt/Market Cap |
0.3107 |
| Effective Tax Rate |
44.1% |
| Enterprise Value Multiple |
17.84 |
MLAB - Mesa Laboratories, Inc.